⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBP News
NovaBridge Biosciences American Depositary Shares
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
globenewswire.com
NBP
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
globenewswire.com
NBP
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
globenewswire.com
NBP
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
globenewswire.com
NBP
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
globenewswire.com
NBP
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
NBP
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
NBP
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
globenewswire.com
NBP
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
globenewswire.com
NBP
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
globenewswire.com
NBP